One of the most exciting conversations I have had all year. Abhi, co-founder and CEO of roots is is a software engineer turned farmer who is really pushing LLMs to the edge of their abilities. In this interview, we discover how he ...

In Bio2040’s latest episode we had the chance to talk to Sam Lee, a long-time veteran of the biotech space. This episode covers some of the history and fundamentals of the synthetic biology and biomanufacturing space.

What are the main challenges in translating scientific innovation from the bench-side to the bedside? Physician and long-term Pharma executive Nadine Martin is now in charge of innovation management at sitem-insel AG. A translational unit of th...

SEED2019 is a scrappy conference targeting innovation within the science publishing & funding process. It will bring together a diverse set of stakeholders and be followed by an incubator to implement the best ideas. We discuss problems and...

How Open Source Drug Discovery can lower the risk and cost of drug discovery. M4K Pharma is pioneering a completely new model, where patents are not filed but data is shared. Yet they are still able to make money.

Peer review is opaque and a large frustration for many scientists. Preprints are becoming more prevalent, but we still need to assess them critically. We shed light on some of the problems and solutions to this with preprint peer review clubs. PRE...

Oskari and Flavio talk about how robots can help humans in biomedical research. UniteLabs is building lab automation systems to automate boring tasks so the highly trained researchers can focus on more high-level activities. We also talk about oth...

What does Open Research mean for the Gates Foundation? Why does it matter? How are they implementing it? We speak with Ashley Farley who is in charge of those initiatives at the Gates Foundation.

In the 2nd part of the interview with Prof. Ernst Hafen we learn about how the birth of the Bio-Technopark Schlieren shows that if innovative entrepreneurs come together with great scientists, magic can happen. We also learn about a big bottlenec...

Lenny is the founder and CEO of protocols.io, where scientists can freely share scientific protocols with each other. Similarly to github, others can then try them out in their own lab, comment on them, improve them or fork them. This leads to man...

In this episode, Prof. Ernst Hafen from ETH Zurich tells us how citizens can play a very important role in biomedical research and drug discovery. Recruiting the right patients for a study is a big challenge for biotech and pharma companies. He pr...

In this episode, we learn how Huntington's disease researcher Rachel Harding uses an open lab notebook to share her findings with the scientific community and writes a blog for a wider audience. Most science is not conducted like that and findings...

Sarah Constantin is a mathematician & data scientist with a PhD from Yale. We discover how computer vision and machine learning can be used to do drug discovery what the biggest challenges in today's cancer research

Prof Paul Glasziou is a practitioner and widely published clinical research expert. He explains how we waste billions of dollars on biomedical research. Over 50% of all health research does not get published at all. From the published r...

In this podcast, we get to know Marcio van Muehlen, a biological engineer from MIT turned entrepreneur & product manager in Silicon Valley. He was working on cancer diagnostics through blood sampling and wanted to have better access to the work fr...